在乳腺癌中,MEF2D作为瘤抑制剂起作用
Xiaoxia Wang1, He Shen1, Yanmin Chen1
1Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, 665 Elm Street, Buffalo, NY 14203, USA.
International journal of molecular sciences
|May 25, 2024
概括
肌细胞增强因子2D (MEF2D) 基因在乳腺癌中起到瘤抑制作用. 它的损失促进癌细胞的生长和扩散,表明其作为治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 遗传学 是一个
背景情况:
- 肌细胞增强因子2 (MEF2) 基因调节关键细胞过程.
- MEF2家族成员可以作为瘤基因或瘤抑制剂.
- 乳腺癌中MEF2D的具体作用尚不清楚.
研究的目的:
- 研究MEF2D转录因子在乳腺癌中的功能.
- 为了确定MEF2D是否在这种情况下起到瘤抑制作用.
主要方法:
- 在小鼠乳腺上皮细胞中MEF2D基因淘汰.
- 细胞表型的分析,包括增殖,接触抑制和独立于 anchorage 的生长.
- 在体内瘤发育的评估.
- 对分子通路的研究,包括表皮细胞到介质细胞的过渡 (EMT) 和信号通路 (AKT,ERK,Hippo-YAP).
- 在人类乳腺癌细胞系和患者组织中分析MEF2D表达.
主要成果:
- MEF2D淘汰赛诱导了瘤转变,其特点是增长的增殖,接触抑制的丧失,以及独立于 anchorage 的生长.
- 在小鼠中,MEF2D缺乏促进了瘤的发展.
- MEF2D损失激活了EMT和瘤信号通道 (AKT,ERK,Hippo-YAP).
- 在人类三阴性乳腺癌细胞系中观察到减少MEF2D表达.
- 低MEF2D表达与较差的患者生存结果相关.
结论:
- 在乳腺癌中,MEF2D作为瘤抑制剂起作用.
- 通过EMT和瘤源途的激活,MEF2D损失有助于乳腺癌的进展.
- 减少MEF2D表达是乳腺癌患者预后不佳的潜在生物标志物.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


